Dr. Reddy’s Laboratories was established in 1984 by Dr. Anji Reddy. It is one of the top pharmaceutical companies in the country. It got listed on the New York Stock Exchange on 11th April 2001; it is the first Asia-Pacific company (outside Japan) to be listed there. The company has developed from a bulk drug (API) manufacture to a vertically integrated global pharmaceutical company.

The company manufactures and markets its products like finished dosages, API (Bulk Actives), and biologics in more than 100 countries. The company has quality, innovation, continuous learning, teamwork, and social responsibility embedded in its core values.
Recently the company has received Global HR Excellence Award for Innovative HR Practices at the Asia-Pacific HRM Congress 2007. It has also received Best Recruitment and Staffing in class
Award for the Best Overall Recruitment and Staffing Organization and Employer Branding Award 2007 for excellence in Human Resources for talent management.

Dr. Reddy’s Lab is into various social initiatives for the prosperity of the society. The various organizations that the company supports are Dr. Reddy’s Foundation, NAANDI Foundation and Centre for Social Initiative & Management (CSIM).

Dr. Reddy's Business-geography matrix
Business Geography
North America European Union Rest of the World
Generics v v x
CPS v v v
Specialty Pharmaceuticals v v v
API v v v
Branded Formulations/ Oncology Biologics x x v

Corporate Address:
Discovery Research
Dr. Reddy’s Laboratories Ltd.
Bollaram Road, Miyapur
Hyderabad 500 049, India
Tel +91 40 2304 5439
Fax +91 40 2304 5438

Quarterly Results (Rs. in Millions)
Dec 2006 (3 rd quarter) Sept 2006(2nd quarter) Dec 2005(3 rd quarter)
Sales Turnover 11704.1 8577 4994.3
Other Income 587.2 1125.1 566.2
Total Income 12291.3 9702.1 5560.5
Total Expenditure 6335.6 6139.4 4430.5
Operating Profit 5955.7 3562.7 1130
Interest 128.8 172.9 46.9
Gross Profit 5826.9 3389.8 1083.1
Depreciation 338.2 330.9 282.5
Tax 453.8 332.3 258.1
Reported PAT 5034.9 2726.6 542.5

*Source: economictimes.indiatimes.com

Quarterly Results (in %)
% Change (Over Sep 2006) % Change (Over Dec 2005)
Sales Turnover 36.46 134.35
Other Income -47.81 3.71
Total Income 26.69 121.05
Total Expenditure 3.2 43
Operating Profit 67.17 427.05
Interest -25.51 174.63
Gross Profit 71.9 437.98
Depreciation 2.21 19.72
Tax
Reported PAT 84.66 828.09

*Source: economictimes.indiatimes.com

Annual Result of Dr. Reddy’s lab

Annual Unaudited Results (Rs. in Millions)
(12 Months) (12 Months) % Changes
Sales Turnover 16250.80 17402.00 -6.62
Other Income 713.4 757.4 -5.81
Total Income 16964.20 18159.40 -6.58
Total Expenditure 15496.40 14394.00 7.66
Operating Profit 1467.80 3765.40 -61.02
Interest 99.6 14.8 572.97
Gross Profit 1368.20 3750.60 -63.52
Depreciation 924.6 717.2 28.92
Tax -211 201.5 -204.71
Reported PAT 654.6 2831.90 -76.88

Recent Updated News of Company

  • Dr Reddy Laboratories has introduced new corporate brand identity

Dr Reddy Laboratories has introduced new corporate brand identity that it call for empathy and dynamism. Empathy will look after patient need and dynamism will enable will them to address those need in innovative way.